Table 5.
Bevacizumab − | Bevacizumab + | P value | |
---|---|---|---|
PET | |||
TP | 29 | 19 | |
True negative (complete response) | 17 | 3 | |
FP | 2 | 2 | |
FN | 20 | 30 | |
Sensitivity | 59% | 39% | 0.068 |
CT | |||
TP | 33 | 31 | |
True negative (complete response) | 13 | 5 | |
FP | 6 | 0 | |
FN | 16 | 18 | |
Sensitivity | 67% | 63% | 0.9 |